MicroRNA
Researchers at the School of Laboratory Medicine have developed a novel diagnostic approach for pulmonary tuberculosis using a circulating microRNA (miRNA) panel. This study aimed to distinguish pulmonary tuberculosis from lung cancer, particularly in patients presenting with overlapping radiographic features. The research team, led by Xiao Liu, analyzed miRNA expression
Cancer research
A new study has shed light on the genetic alterations and microRNAs (miRNAs) that play a crucial role in lung cancer progression. According to the research, lung cancer is the most frequently diagnosed type of cancer worldwide, with key genetic alterations involving driver gene mutations that significantly enhance cancer aggressiveness.
Cancer research
A study published in the Journal of Thoracic Disease has found that elderly patients undergoing lung cancer surgery are at a high risk of developing postoperative atrial fibrillation (POAF), which can lead to serious complications such as heart failure, myocardial infarction, pulmonary embolism, and ischemic stroke. The study aimed to
Cancer research
Researchers from Chongqing University have developed a machine learning model using clinical laboratory data to predict lymph node invasion and skip metastasis in lung cancer. The study analyzed 1,629 cases of lung cancer, categorizing them into two groups based on the TNM stage: Group N (861 cases) and Group
Cancer research
Asian Americans are at a higher risk of being diagnosed with lung cancer at a distant stage of the disease and are less likely to receive smoking cessation advice compared to the general US population. A recent study conducted by researchers from the University of Massachusetts Boston aimed to investigate
Cancer research
Researchers at the Yale University School of Medicine have made a significant breakthrough in understanding the role of asparagine-linked glycosylation protein 1 (ALG1) in lung cancer progression. According to a newly published study, ALG1 promotes aggressive phenotypes of lung adenocarcinoma cells by modulating N-linked glycosylation and endoplasmic reticulum (ER)-stress
Cancer metastasis
Research conducted by Jian Wang and colleagues has shed new light on the mechanisms underlying lung cancer metastasis. The study, published in the International Journal of Oncology, highlights the crucial role of exosomal microRNAs in promoting metastasis and explores their potential as diagnostic indicators and therapeutic targets. Lung cancer is
Cancer research
Researchers at the Yale University School of Medicine have made a significant breakthrough in understanding the role of asparagine-linked glycosylation protein 1 (ALG1) in lung cancer progression. According to a newly published study, ALG1 promotes aggressive phenotypes of lung adenocarcinoma cells by modulating N-linked glycosylation and endoplasmic reticulum (ER)-stress
Cancer research
Researchers at IMVARIA Inc. have achieved a major technological advancement in the development of a fully-automated Bronchosolve solution, designed to diagnose lung cancer non-invasively through the assessment of suspicious pulmonary nodules. The platform, which has been tested in the pivotal VIRTUAL-BRONCH Study, has demonstrated improved accuracy relative to standard clinical
Cancer research
Researchers have identified the Advanced Lung Cancer Inflammation Index (ALI) as a valuable predictor of colon cancer risk in elderly patients. By incorporating body mass index (BMI), serum albumin, and neutrophil-to-lymphocyte ratio (NLR), the ALI composite index reflects both nutritional and systemic inflammatory states. The study, conducted by a team
Cancer research
Researchers from the First Affiliated Hospital of Zhengzhou University have discovered that immunotherapy can be enhanced to treat metastatic lung cancer. The study, published in Cancer Immunology, Immunotherapy, found that tumor-associated macrophages (TAMs) contribute to immune suppression in lung cancer by limiting the activation of CD8 T cells and cytokine
Cancer research
A significant reduction in new lung cancer diagnoses was observed in Romania during the first year of the COVID-19 pandemic, with a 72% decrease in diagnoses compared to the pre-pandemic period. A 5-year retrospective study published in the journal Medicina found that the temporal trend of lung cancer diagnosis followed
